Left Atrial Enlargement in Athletes: Physiologic Adaptation or Pathology?
Published on: February 25, 2026
Left Atrial Enlargement in Athletes Physiologic Adaptation or Pathology featured image
  • Article reviewer photo

    Naira Djuniardi

    MPharm Pharmacy, King’s College London

  • Article reviewer photo

    Paramvir Singh

    RPh; Master of Pharmacy (MPharm), Pt BD Sharma University of Health Sciences, India

Introduction

Regular exercise modifies and controls cardiovascular risk by 35%, establishing it as a critical component of long-term heart health.1 However, intense endurance training puts the heart under stress.2 In populations of athletes, could this be described as too much of a good thing? 

Structural changes in the heart with physical exertion are an interesting adaptation, not yet fully understood.3 In athletes, these physiological responses have been predominantly researched in the lower chambers, called ventricles.4 This means data for the upper chambers, or atria, is based on speculation.5

One of these changes, called atrial enlargement, is a key predictor for certain heart conditions.3 Without enough data, this raises concerns about whether the change is physiological or pathological. Understanding the differences between adaptation and pathology is key to making informed decisions about your health. 

A closer examination of atrial enlargement is needed for athletes. This article examines cause, concerns, and misconceptions to provide clarity to the issue and help determine whether they are normal or pathological changes. 

The role of the left atrium

The left atrium is one of four main heart chambers and the first stop for oxygenated blood in the heart. This upper chamber coordinates blood delivery to the ventricles from the lungs, acting as an almost loading dock to ensure the system remains balanced and effective.6 

This occurs through the three following and distinct phases:

  • Reservoir phase: This occurs when the ventricles are contracting to pump blood throughout the body (systole). During this, the atrium closes its valve to prevent blood from flowing into the ventricle and allowing it to fill with oxygenated blood from the lungs. Here, the atria act as a storage site in preparation for later stages of the cardiac cycle
  • Conduit phase: When the ventricle relaxes (diastole), the valve in the atrium opens and allows blood to flow into the ventricle through gravity and pressure differences
  • Booster pump phase: Right before the next ventricular contraction, the atrium contracts and actively pushes blood into the ventricle

The left atrium has a precisely timed job; its role is important during physical exercise, where the body’s demand for oxygen increases. To achieve this, the heart must pump more blood over the same amount of time (increase cardiac output), which can be increased up to 6 times over resting rates,7 and find ways to adapt to the increased workload. 

Causes of left atrial enlargement

Endurance athletes (e.g. rowers, runners, cyclists) train in a pattern that causes prolonged volume overload. This means the heart is repeatedly required to pump larger volumes of blood to keep up with athletic demands. For the atrium, more blood flows from the lungs over the same timeframe. To adapt, its size can increase up to 30%,2 owing to repeated stretching that over time causes remodelling.6 These changes occur after 3-4 months of intensive training, considered a normal response and reversible if training is reduced.2 

What is the concern?

Left atrial enlargement in athletes mirrors anatomical changes seen in the early stages of heart disease.2 Importantly, in the general population, left atrial enlargement is recognised as a significant risk factor for atrial fibrillation (AF), a heart rhythm disorder that increases the chance of stroke and heart failure.3 The overlap with disease-associated changes has raised concerns about long-term risk, especially as the incidence of atrial fibrillation continues to rise in the general population.5

Understanding the differences/misconceptions

The key differences highlight inconsistencies in clinical markers between physiologic and pathologic left atrium enlargement.

In pathological left atrium enlargement, this is usually a warning sign and reflects the heart's inability to cope with increased pressure or damage.8 In this case, people often experience fatigue, shortness of breath and palpitations.8 This type of enlargement is usually uneven,9 gets worse over time, and increases the risk of a heart rhythm disorder called atrial fibrillation, which can lead to stroke or heart failure.5

In physiologic left atrium enlargement experienced by well-trained athletes, this is usually a normal and healthy response to years of intense exercise.10 The heart adapts to pump increased volumes of blood and reflects an even enlargement across all chambers.11 This is linked to normal or even above average heart function.10 With no symptoms, it is reversible if athletes undergo recovery periods without intense exercise.2

However, long-term endurance athletes who train intensely for decades may have a slightly higher chance of developing atrial fibrillation later in life. These athletes had a 2 to 10 times greater risk than non-athletes.12 This could be due to years of repeated stress on the heart, small amounts of scarring, and changes in the way the heart’s electrical signals work. It is important to remember that this risk mainly shows up with age and after many years of intense training.

Ultimately, not all left atrial enlargement is harmful, and while long-term endurance training may raise the risk of AF, it doesn’t mean exercise is dangerous. Instead, understanding whether this is a normal adaptation or a sign of disease requires a more detailed look into symptoms and causes. Balance and context in this case are key.

Diagnostic challenges and knowledge gaps

Using only visual evaluations presents difficulties in determining the cause of left atrial enlargement. Historically, research and diagnostic criteria have focused on changes that occur within the ventricles,4 leaving changes seen in the atria to be implied rather than evidenced. Furthermore, current research highlights several important knowledge gaps, as data is limited on people assigned female at birth and non-elite athletes, imaging tools like 2D echocardiography can often miss details of the heart's structure, and there is a lack of standardised reference ranges for what is considered a normal left atrium size in different types of athletes.4,13 This therefore makes it difficult to draw accurate conclusions.

Understanding Underlying Factors

Even within the subgroups of the athletes’ context is a need. Individual factors mean that left atrium enlargement is not experienced equally:

  • Type of sport: Endurance sports are more likely to cause left atrial enlargement than strength-based sports, owing to the sustained increase in blood flow and cardiac output2,10
  • Training volume and history: The heart remodels over time in response to increased stress. This means athletes who have trained intensively and consistently for years are predisposed to bigger changes2,3
  • Sex (biological differences): People assigned male at birth tend to exhibit more significant left atrium enlargement than people assigned female at birth, which may relate to the differing action of sex hormones14
  • Body size: Larger athletes naturally have larger heart chambers to meet the demands of their bodies. This means naturally larger atria15 

What should athletes do?

  • Understanding your baseline: Regular check-ups and heart imaging can track changes over time
  • Watch for symptoms: While most athletes with LAE are symptom-free, stay alert to palpitations, dizziness, or fatigue
  • Consult a sports cardiologist: They can distinguish between healthy adaptations and any potential red flags
  • Consider detraining: In some cases, reducing training temporarily can help determine if enlargement is reversible (a sign of non-worrying adaptation)

Summary

Left atrial enlargement is not inherently dangerous but does represent a more nuanced grey area needing further scientific research. In athletes, it often reflects a healthy, well-conditioned and balanced enlargement of the heart. However, because it can also appear in heart disease, it’s essential to evaluate changes in the broader context of your health, symptoms, and lifestyle.

Understanding the difference between physiological adaptation and pathology allows athletes to train confidently and recognise when it’s time to seek further help. As our knowledge grows, so too does our ability to protect long-term heart health and unpick when left atrial enlargement is an issue.

References

  1. British Heart Foundation. Benefits of exercise [Internet]. London: BHF; [cited 2025 Jun 13]. Available from: https://www.bhf.org.uk/informationsupport/support/healthy-living/staying-active#:~:text=get%20in%20touch.-,Benefits%20of%20exercise,control%20your%20weight
  2. D’Ascenzi F, Anselmi F, Focardi M, Mondillo S. Atrial enlargement in the athlete’s heart: assessment of atrial function may help distinguish adaptive from pathologic remodeling. J Am Coll Cardiol [Internet]. 2018 Nov 6 [cited 2025 Jun 13]. Available from: https://www.acc.org/Latest-in-Cardiology/Articles/2018/11/06/05/58/Atrial-Enlargement-in-the-Athletes-Heart
  3. Pelliccia A, Maron BJ, De Luca R, Di Paolo FM, Spataro A, Culasso F. Prevalence and clinical significance of left atrial remodeling in competitive athletes. J Am Coll Cardiol. 2005 Aug 16;4610:690–6. doi:10.1016/j.jacc.2005.04.052
  4. Pina IL, Apstein CS, Balady GJ, Belardinelli R, Chaitman BR, Duscha BD, et al. Exercise and heart failure: a statement from the American Heart Association Committee on Exercise, Rehabilitation, and Prevention. Circulation. 2003 Mar 4;1077:1210–25. doi:10.1161/01.CIR.0000055013.92097.40
  5. Heitmann KA, Løchen ML, Stylidis M, Hopstock LA, Mathiesen EB, Løchen ML. Associations between physical activity, left atrial size and incident atrial fibrillation: the Tromsø Study 1994–2016. Open Heart. 2022;92:e001823. doi:10.1136/openhrt-2021-001823
  6. Elliott AD, Ariyaratnam J, Howden EJ, La Gerche A, Sanders P. Influence of exercise training on the left atrium: implications for atrial fibrillation, heart failure, and stroke. Am J Physiol Heart Circ Physiol. 2023;32510:H822–36. doi:10.1152/ajpheart.00322.2023
  7. Sanfilippo AJ, Abascal VM, Sheehan M, Oertel LB, Harrigan P, Hughes RA, et al. Atrial enlargement as a consequence of atrial fibrillation: a prospective echocardiographic study. Circulation. 1990;825:792–7. doi:10.1161/01.CIR.82.3.792
  8. Cleveland Clinic. Left atrial enlargement [Internet]. Cleveland (OH): Cleveland Clinic; [cited 2025 Jun 13]. Available from: https://my.clevelandclinic.org/health/diseases/23967-left-atrial-enlargement
  9. Henry WL, Morganroth J, Pearlman AS, Clark CE, Redwood DR, Itscoitz SB, et al. Asymmetric left atrial enlargement: an echocardiographic observation. Chest. 1976;696:779–81. doi:10.1378/chest.69.6.779
  10. Trivax JE, Franklin BA, Goldstein JA, Chinnaiyan KM, Gallagher MJ, deJong AT, et al. Acute cardiac effects of marathon running. J Appl Physiol (1985). 2010 Nov;1094:1235–40. doi:10.1152/japplphysiol.99005.2009
  11. DeSanctis RW, Dean DC, Bland EF. Extreme left atrial enlargement: some characteristic features. Circulation. 1964;29:14–23. PMID:14105025
  12. Rode JC, Klöting I, Dahlmann A, Dieterich C, Tsokos M, Schulze PC, et al. The left atrium as a biomarker of cardiovascular risk in people living with obesity. J Clin Med. 2024;13(24):7691. doi:10.3390/jcm13247691
  13. Díaz-Babio G, Vera Janavel G, Constantin I, Gutiérrez L, Segovia J, Fernández Lozano I, et al. Left atrial enlargement in competitive athletes. Rev Esp Cardiol (Engl Ed). 2021;749:839–46. doi:10.1016/j.rec.2021.02.015
  14. Christou GA, O’Driscoll JM. The impact of demographic, anthropometric and athletic characteristics on left atrial size in athletes: a systematic review. Clin Cardiol. 2020;437:834–42. doi:10.1002/clc.2336815. Caminiti G, Perrone MA, D’Antoni V, Marazzi G, Gismondi A, Vadalà S, et al. The improvement of left atrial function after twelve weeks of supervised concurrent training in patients with heart failure with mid-range ejection fraction: a pilot study. J Cardiovasc Dev Dis. 2023;101:276. doi:10.3390/jcdd10070276

Share

Constantine Eleftheriou

Master of Science - MS, Advanced Biological Sciences, University of Exeter

arrow-right